Detalles de la búsqueda
1.
Predicting the clinical outcomes and benefit from letrozole after 5 years of treatment with aromatase inhibitors for early breast cancer: analysis from CCTG MA.17R.
Breast Cancer Res Treat
; 191(3): 523-533, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34825307
2.
Single-nucleotide polymorphism biomarkers of adjuvant anastrozole-induced estrogen suppression in early breast cancer.
Pharmacogenet Genomics
; 31(1): 1-9, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32649577
3.
Patient Navigation to Improve Early Access to Supportive Care for Patients with Advanced Cancer in Resource-Limited Settings: A Randomized Controlled Trial.
Oncologist
; 26(2): 157-164, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33210345
4.
Breast cancer in Colombia: a growing challenge for the healthcare system.
Breast Cancer Res Treat
; 186(1): 15-24, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33611666
5.
Phase II trial of veliparib and temozolomide in metastatic breast cancer patients with and without BRCA1/2 mutations.
Breast Cancer Res Treat
; 189(3): 641-651, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34417675
6.
Deep sequencing across germline genome-wide association study signals relating to breast cancer events in women receiving aromatase inhibitors for adjuvant therapy of early breast cancer.
Pharmacogenet Genomics
; 29(8): 183-191, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31211741
7.
Patient Navigation to Enhance Access to Care for Underserved Patients with a Suspicion or Diagnosis of Cancer.
Oncologist
; 24(9): 1195-1200, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30498134
8.
Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.
N Engl J Med
; 375(3): 209-19, 2016 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-27264120
9.
Discrepancy in risk assessment of hormone receptor positive early-stage breast cancer patients using breast cancer index and recurrence score.
Breast Cancer Res Treat
; 173(2): 375-383, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30350269
10.
Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03).
Breast Cancer Res Treat
; 169(3): 537-548, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29455298
11.
TCL1A, a Novel Transcription Factor and a Coregulator of Nuclear Factor κB p65: Single Nucleotide Polymorphism and Estrogen Dependence.
J Pharmacol Exp Ther
; 365(3): 700-710, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29592948
12.
TCL1A Single-Nucleotide Polymorphisms and Estrogen-Mediated Toll-Like Receptor-MYD88-Dependent Nuclear Factor-κB Activation: Single-Nucleotide Polymorphism- and Selective Estrogen Receptor Modulator-Dependent Modification of Inflammation and Immune Response.
Mol Pharmacol
; 92(2): 175-184, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28615284
13.
Improving access to high-cost cancer drugs in Latin America: Much to be done.
Cancer
; 123(8): 1313-1323, 2017 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28182258
14.
Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27.
Cancer
; 123(13): 2444-2451, 2017 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28464211
15.
Barriers to Primary Debulking Surgery for Advanced Ovarian Cancer in Latin America.
Int J Gynecol Cancer
; 27(8): 1645-1649, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28857784
16.
Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study.
Breast Cancer Res
; 18(1): 1, 2016 Jan 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-26728744
17.
Prolactin and breast cancer: The need to avoid undertreatment of serious psychiatric illnesses in breast cancer patients: A review.
Cancer
; 122(2): 184-8, 2016 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26457577
18.
Cervical cancer control in Latin America: A call to action.
Cancer
; 122(4): 502-14, 2016 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26670695
19.
Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27.
Breast Cancer Res Treat
; 156(2): 343-9, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27006189
20.
Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14.
Breast Cancer Res Treat
; 157(1): 101-8, 2016 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27116182